Parker, formerly of Napster and Facebook, knows the power of networking, so he was surprised when he found that many cancer researchers didn’t collaborate. With the Parker Institute for Cancer Immunotherapy, he supports and connects the world’s best cancer doctors to speed new treatments. Its work led to the first approved gene immunotherapy for blood cancers, as well as a Nobel Prize this year for immune-based cancer drugs (see Allison and Honjo). —Alice Park
Next Up
Most Popular Stories
More Coverage
More from TIME.com
TIME may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.